Drug Database
Back to search

Netherlands· NL-bdb496638fa6

Lobiretic 5 mg/25 mg, filmomhulde tabletten

A nebivolol und thiazide product containing hydrochloorthiazide + nebivololhydrochloride, registered in Netherlands by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC C07BB12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLobiretic 5 mg/25 mg, filmomhulde tab…ATCC07BB12REGISTER NO.NL-bdb496638fa6PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydrochloorthiazide + nebivololhydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nebivolol und thiazide is registered in 9 of 19 countries.

Countries holding a registration under ATC C07BB12 (nebivolol und thiazide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search nebivolol und thiazide products by name

Nebivolol und thiazide · ATC C07BB12

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROCHLOORTHIAZIDE + NEBIVOLOLHYDROCHLORIDE
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Netherlands (NL)
ATC code
C07BB12
ATC class
Nebivolol und Thiazide
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    35173

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C07BB12

Nebivolol und thiazide, as other registers publish it.

All nebivolol und thiazide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8453f641-20f0-4afa-a374-d9b82b9d772d
GET /v1/drugs/8453f641-20f0-4afa-a374-d9b82b9d772d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h35173_smpc.pdf",
  "strength": null,
  "atc_label": "Nebivolol and thiazides",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg35173",
  "excipients": [
    "CARMINEZUUR ALUMINIUM LAK (E 120)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOLSTEARAAT, TYPE I",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "HYDROCHLOORTHIAZIDE",
    "NEBIVOLOLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h35173.pdf",
  "authorised_at": "2009/02/27",
  "procedure_number": "NL/H/1069/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "35173",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nebivolol und thiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console